Nasdaq Stockholm Welcomes Oncopeptides to the Main Market (NASDAQ OMX Nordic - NASDAQ OMX Stockholm AB)
(WorldNews Denmark)

(Source: NASDAQ OMX Nordic - NASDAQ OMX Stockholm AB) Nasdaq Nordic Nasdaq Stockholm Welcomes Oncopeptides to the Main Market Stockholm, February 22, 2017 - Nasdaq (Nasdaq: NDAQ) announced that Oncopeptides AB (short name: ONCO), a mid cap company within the health care sector, has started trading of its shares on the main market of Nasdaq Stockholm. Oncopeptides is the 5 company to list at Nasdaq`s Nordic markets* in 2017. Founded in 2000, Oncopeptides is a research-based pharmaceutical company based in Stockholm, Sweden. The company`s product candidate, Ygalo, is based on the active compound melflufen and is intended for the treatment of patients with multiple myeloma - a blood cancer...